Chorea: Clinical Trials

3 trials for Chorea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Unknown 3
Phase 22Unknown 2

Follow Chorea: new trials by email Literature Review of Chorea trials Research Report on Chorea

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of NestaCell® in Huntington's Disease
NestaCell® - Huntington Disease
Phase 3UnknownAzidus Brasil1202024-06-082023-10-24
Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients.
Cellavita-HD - Huntington Disease
Phase 2 / Phase 3UnknownAzidus Brasil352020-02-102022-10-28
Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)
RP103, Placebo - Huntington's Disease
Phase 2 / Phase 3UnknownUniversity Hospital, Angers962010-10-012014-04-02

Narrower conditions

Huntington Disease (3)

Broader conditions

Basal Ganglia Diseases (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Cognition Disorders (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Dementia (3)  ·  Dyskinesias (3)  ·  Genetic Diseases, Inborn (3)  ·  Heredodegenerative Disorders, Nervous System (3)  ·  Mental Disorders (3)  ·  Movement Disorders (3)  ·  Nervous System Diseases (3)  ·  Neurocognitive Disorders (3)  ·  Neurodegenerative Diseases (3)

Interventions

Cell- and Tissue-Based Therapy (1)

Sponsors

Azidus Brasil (2)  ·  University Hospital, Angers (1)

Countries

Brazil (1)  ·  France (1)

Top investigators

Joyce Macedo, MD (1)  ·  Luciana Ferrara, Doctor (1)